Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies William Suciangto; Haerani Rasyid; Anastasya Angelica Vicente; Winny Suciangto;

El KFRE como criterio de remisión a las consultas de enfermedad renal crónica avanzada Eduardo Gallego-Valcarce; Angela Rey-Cárdenas; Eva López-Melero; Ana María Tato-Ribera; Deborah Roldan; Sofia López San Román; Ángel Méndez Abreu; Clara Cases- Corona; Enrique Gruss;

Healthcare resource utilization and costs of chronic kidney disease in Spain across KDIGO categories: insights from real-world evidence Rafael Santamaria; Carlos Escobar; Unai Aranda; Beatriz Palacios; Margarita Capel; Ignacio Hernández; Ana Cebrián; Roberto Alcázar; Manuel Gorostidi;